Background: Neuropathic pain is the most widely accepted term for non-nociceptive pain. The most obvious difference from nociceptive pain is the absence of a continuous nociceptive stimulus. The present study was conducted to assess of neuropathic pain features in COVID 19 patients. Materials & Methods: 48 COVID 19 patients with neuropathic pain of both genders were divided into positive (+) and negative (-) according to the PCR test results. Average values of pain intensity and Neuropathic Pain Questionnaire items were recorded. Results: Out of 48 patients, males were 28 and females were 20. In PCR +ve and PCR -ve subjects, the mean pain intensity (0-10) was 6.7 and 5.2, burning pain was 4.6 and 2.3, neuropathic pain questionnaire score was 0.16 and 0.02, throbbing pain was 4.5 and 3.1, electric pain was 3.7 and 1.2, numbness was 4.2 and 1.5, squeezing pain was 2.3 and 2.8, freezing pain was 3.9 and 0.92. How unpleasant was your usual pain score was 5.9 and 5.4, How annoying was your usual pain was 5.0 and 4.1, increased pain due to weather changes was 3.7 and 1.5, increased pain due to touch was 3.9 and 1.9 respectively. The difference was significant (P< 0.05). Conclusion: The frequency of neuropathic pain was significantly higher in PCR confirmed COVID 19 patients at the onset of the disease.